Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  _______________ FORM 8-K  _______________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report:  May 22, 2024 (Date of earliest event reported)  _______________ TENET HEALTHCARE CORP ORATION (Exact name of registrant as specified in its charter)   Nevada   1-7293   95-2557091 (State of Incorporation)   (Commission File Number)   (IRS Employer Identification Number) 14201 Dallas Parkway Dallas , TX   75254 (Address of principal executive offices, including zip code) ( 469 ) 893-2200 (Registrant’s telephone number, including area code)  _______________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.05 par value THC NYSE 6.875% Senior Notes due 2031 THC31 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).     Emerging Growth Company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ☐ Item 5.07. Submission of Matters to a Vote of Security Holders. The 2024 Annual Meeting of Shareholders (the “Annual Meeting”) of Tenet Healthcare Corporation (the “Company”) was held on May 22, 2024 . Below are the final voting results from the meeting. 1.    The Company’s shareholders elected the following directors to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal: FOR AGAINST ABSTAIN BROKER NON-VOTES Saumya Sutaria 78,408,106  2,952,599  32,017  7,127,343  J. Robert Kerrey 79,073,669  2,287,690  31,364  7,127,343  Vineeta Agarwala 81,165,083  196,130  31,509  7,127,343  James L. Bierman 80,681,369  679,552  31,802  7,127,343  Roy Blunt 80,901,184  459,196  32,343  7,127,343  Richard W. Fisher 80,876,576  483,410  32,737  7,127,343  Meghan M. FitzGerald 79,983,800  1,373,328  35,595  7,127,343  Cecil D. Haney 80,749,317  612,662  30,744  7,127,343  Christopher S. Lynch 80,998,870  361,100  32,753  7,127,343  Richard J. Mark 80,881,920  478,921  31,882  7,127,343  Tammy Romo 80,830,618  530,853  31,252  7,127,343  Stephen H. Rusckowski 81,110,163  250,471  32,089  7,127,343  Nadja Y. West 80,637,096  723,225  32,401  7,127,343  2.    The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation: FOR AGAINST ABSTAIN BROKER NON-VOTES 78,324,154 2,920,906 147,662 7,127,343  3.     The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2024: FOR AGAINST ABSTAIN BROKER NON-VOTES 87,988,280 496,790 34,996 — 4.     The shareholder proposal requesting a report on risk mitigation regarding state restrictions for emergency abortions did not pass. FOR AGAINST ABSTAIN BROKER NON-VOTES 4,059,525 75,912,077 1,421,120 7,127,343 5.    The shareholder proposal requesting a report on plans to integrate ESG metrics into executive compensation did not pass. FOR AGAINST ABSTAIN BROKER NON-VOTES 4,328,821 76,596,569 467,332 7,127,343 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TENET HEALTHCARE CORPORATION Date: May 23, 2023 By: /s/ T HOMAS A RNST Name: Thomas Arnst Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary